AUM Biosciences Pte Ltd

AUM Biosciences is a clinical stage oncology-focused biotechnology company committed to increase accessibility and affordability of cancer therapeutics.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Singapore
  • Currency USD
  • Founded March 2018
  • Employees 8
  • Incorporation Type Not Incorporated
  • Website aumbiosciences.com

Company Summary

AUM Biosciences is an oncology-focused biotechnology company committed to developing targeted cancer therapies. AUM was founded by industry veterans supported by team with over 100 years track record in the drug development industry. An example includes execution and exiting a $145M private equity project finance model with Eisai Pharmaceuticals. This virtual drug development model lead to the global commercialization of 3 major successes.

Team

  • Vishal Doshi
    CEO

  • Harish Dave
    Chief Medical Officer

    Board-certified oncologist and hematologist with more than 35 years of experience

  • Terig Hughes
    Chief Financial Officer

    Over 25 years of international experience in healthcare, scientific and medical publishing, information and analytics

  • Dr. John Patava
    Chief Operating Officer

    25 years of experience in medical research and clinical development of therapeutics products, including a 10-year period leading clinical operations at Bayer

  • Dr. Zou Bin
    Chief Scientific Officer

    Previously worked at Shanghai Blueray Biopharma, Co., Ltd. as CEO and Co-founder, and was responsible for developing a strong pipeline of lymphoma/lung cancer drugs, taking the company’s value to more than 100 million RMB.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free